The HALO program is a strategic initiative designed to accelerate the development and deployment of advanced space technologies. With this program, the SDA aims to foster competition, drive innovation ...
On Monday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $51.77 which represents a decrease of $-0.84 or -1.60% from the prior close of $52.61. The stock opened at $52.6 ...